FDA approves Immucor’s device to detect sickle cell trait in blood

The Food and Drug Administration recently approved Norcross, Ga.–based Immucor’s PreciseType HEA test to screen blood donations for the sickle cell trait.

Advertisement
By: Mackenzie Bean

The test, first approved in 2015, helps clinicians predict blood compatibility between donors and patients.

Typically, blood banks use solubility testing to screen for the sickle cell trait. Immucor’s new molecular approach to identifying the trait aims to increase efficiency and limit the rate of false positives, according to the report.

More articles on supply chain:

Medical device execs call for quicker coverage decisions from CMS
States ranked by 2015 generic drug savings
4 latest FDA approvals

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott launches residual cancer test

    Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

    By: Elizabeth Gregerson

  • Supply chain leaders' $1M wish lists

    Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

    By: Ella Jeffries

  • 10 systems seeking supply chain leaders

    As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

    By: Ella Jeffries
Advertisement

Comments are closed.